Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
December 16, 2019 Off

Platelet BioGenesis Receives $2.3 Million Award from the Medical Technology Enterprise Consortium to Accelerate Development of Donor-Independent Platelet Production

By BusinessWire

Company also bolsters Scientific Advisory Board with Additions of Uma Lakshmipathy, Ph.D. and Teresa Foy, Ph.D. CAMBRIDGE, Mass.–(BUSINESS WIRE)–Platelet BioGenesis,…

December 16, 2019 Off

 Exicure Announces First Neurological Development Program in Friedreich’s Ataxia and Expands Scientific Advisory Board

By BusinessWire

 – Exicure to collaborate with Friedreich’s Ataxia Research Alliance (FARA) – Hank Paulson, MD, PhD and Susan Perlman, MD, added…

December 16, 2019 Off

Rocket Pharmaceuticals Receives the European Medicines Agency PRIME Eligibility for RP-L102 Gene Therapy for Fanconi Anemia

By BusinessWire

– Milestone Gives Fanconi Anemia Program All Accelerated Regulatory Tools in U.S. and EU, Including FDA Regenerative Medicine Advanced Therapy,…

December 16, 2019 Off

Charles River Laboratories to Acquire HemaCare Corporation

By BusinessWire

– Expands Charles River’s Scientific Capabilities in the High-Growth Cell Therapy Market – – Establishes a Comprehensive Cell Therapy Solution…

December 16, 2019 Off

NantKwest and ImmunityBio Present Results of Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy With Durable, Complete Response Data and 78% Disease Control in Refractory Triple Negative Breast Cancer at SABCS

By BusinessWire

World’s first combination of off-the-shelf NK with checkpoint inhibitor plus antigen simulation via adenovirus to induce immune system activation Ongoing…

December 16, 2019 Off

Amneal Appoints Jeff George, John Kiely and Shlomo Yanai to Board of Directors

By BusinessWire

Three Independent Directors Bring Significant Pharmaceutical, Healthcare and Financial Expertise and Track Records of Creating Value for Shareholders BRIDGEWATER, N.J.–(BUSINESS…

December 16, 2019 Off

Eagle Pharmaceuticals Granted Orphan Drug Designation for RYANODEX (dantrolene sodium) for Treatment of Organophosphate Exposure (Nerve Agents)

By BusinessWire

WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the U.S. Food and Drug…

December 16, 2019 Off

Avivagen Signs Memorandum of Understanding with Distribution Agent in Asia-Pacific

By BusinessWire

Deal with Manila-based INPHILCO intended to create new channel for OxC-betaTM Livestock with large integrated feed producers and commercial farms…

December 16, 2019 Off

Humana to Acquire Enclara Healthcare

By BusinessWire

LOUISVILLE, Ky. & PHILADELPHIA–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) today announced it has signed a definitive agreement to acquire privately held…

December 16, 2019 Off

FSD Pharma Receives Approval to List Its Shares on Nasdaq

By BusinessWire

TORONTO–(BUSINESS WIRE)–#FSDDF—FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) announces that Nasdaq has approved…

Posts pagination

Previous 1 … 5,175 5,176 5,177 … 6,133 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

November 13, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine